БЕСПЛАТНЫЙ ПРОСМОТР ОТДЕЛЬНЫХ ОНЛАЙН МЕРОПРИЯТИЙ КОНГРЕССОВ ЕНА, ASCO, ICML

Guideline Updates and Real-World Experiences in CLL: Experts Review State-of-the-Art Evidence and Address Next Questions

CCO/NCCN | Multi-supported | Faculty – Weirda, Abramson, Mato

Virtual Live Date  – June 8, 2021; 7-8:30 PM ET;

Registration Link:  www.clinicaloptions.com/ChicagoNCCNCLL2021

New Standards for CLL Care With BTK Inhibitors: Using Evidence to Make Personalized Choices in Treatment-Naïve and Relapsed Disease 

PeerView | Sole-supported | Faculty – Weirda, Lamanna, Rogers

Virtual Live Date – June 9, 2021; 6:30-8 PM ET;

Registration Link:  www.PeerView.com/CLL21Live

Pushing the Boundaries in CLL:  A Guide to the Convergence of Targeted Therapy, Novel Combinations and Precision Medicine in Patient Care

PeerView | Multi-supported I Faculty – Davids, Jain, Stephens

Virtual Live Date – June 14, 2021; 6:30 – 8 PM ET;

Registration Link:  https://learn2.peerview.com/150206867_1/150206867_1_p1/stage1reg?Promocode=700&ProjectNumber=150206867_1

Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Patients with Multiple Myeloma, CLL and Hodgkin and Non-Hodgkin Lymphomas

RTP | Multi-supported I Faculty – Kahl, Gribben, Sehn

Virtual Live Date – June 29, 2021; 5-6:30 PM ET;

Registration Link:  http://www.researchtopractice.com/Meetings/SummerWebinars21

Thursday, June 10, 2021 – 8:30 – 10:00 AM CEST – (Live Webinar)

Evolving Therapeutic Strategies Using BTK Inhibitors in CLL: Guidance on a Selective Approach to Improve

Patient Outcomes

Med Ed Provider – CCO – Sole-Supported by AZ – Grant #64168177

Faculty: Ghia, Follows, LeBlond

Registration Link:  http://clinicaloptions.com/EHA2021CLLJoin1

Anticipated Attendance: 600 June 10th; *Enduring will be launched following ICML (One grant was funded with CCO for both EHA and ICML)

Learning Objectives: